Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Vaccine manufacturing: Challenges and solutions

Article Abstract:

The application of new technologies to discover, assess, develop and produce the vaccines has the potential to prevent shortages of vaccines during an epidemic and enable the introduction of new vaccines, but increased cost of production and regulatory uncertainty created challenges for vaccine manufacturers. The cost of production can be reduced by growing vaccine virus in tissue culture cells, which enables rapid manufacturing, better controlled and increased large-scale vaccine production.

Author: Rappuoli, Rino, Ulmer, Jeffrey B., Valley, Ulrich
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
Drugs, Biological products industry, Vaccines, Tissue culture

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Public-private collaborations and the race to sequence Agrobacterium tumefaciens

Article Abstract:

Gene Nester the head of the research group on Agrobacterium tumefaciens did not receive a favourable response from the public authorities for funding purposes and so he approached the private corporations to work in collaboration towards the project. The genome race for Agrobacterium tumefaciens indicates that a natural or fixed classification of labour between the public and private sectors is very much unsophisticated.

Author: Harvey, Mark, McMeekin, Andrew
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Surveys, Public opinion, Work, Agrobacterium tumefaciens, Labour, Labor, Public-private sector cooperation, Nester, Gene

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Commercializing cognitive neurotechnology-the ethical terrain

Article Abstract:

Neurotechnology can be effectively used in the treatment of neurodegenerative and psychiatric disorders. The ethical and social concerns related to the development of neurotechnological therapies like, free will, identity, privacy and mental health, integrity of published data are discussed in the article.

Author: Eaton, Margaret L., Illes, Judy
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Ethics, Social aspects, Care and treatment, Analysis, Ethical aspects, Mental illness, Mental disorders, Medical ethics, Cognitive neuroscience

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, United States, Management, Company business management
Similar abstracts:
  • Abstracts: R&D-marketing integration in Japanese high-technology firms: hypotheses and empirical evidence. Correlates of decision making autonomy in marketing units: a study of Canadian advanced technology manufacturing companies
  • Abstracts: Challenges to existing strategy theory in a postindustrial society. Prospects for developing absorptive capacity through internal information provision
  • Abstracts: Taking the load off: investigations of how adaptive cruise control affects mental workload. Validating task analysis for error identification: Reliability and validity of a human error prediction technique
  • Abstracts: Sega's derby owners club in Ireland. Time is no longer waiting in the wings of capital city
  • Abstracts: Stars of the new Russia . Stars of the new Russia. The world's biggest banks 2004
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.